Novel Machine Learning Algorithm for Prevalent Gene Biomarkers for Effective Cancer Treatment by Detecting its PH

Abstract

Patterns discovered from based on collected molecular profiles of patient tumour samples, and also clinical metadata, could be used to provide personalized cancer treatment to patients with similar molecular subtypes. Computational algorithms for cancer diagnosis, prognosis, and therapeutics that can recognize specific functions and aid in classifiers based on a plethora of publicly accessible cancer research outcomes are needed. Machine learning, a branch of artificial intelligence, has a great deal of potential for problem solving in cryptic cancer datasets, as per a literature study. We focus on the new state of machine learning applications in cancer research in this study, illustrating trends and analysing major accomplishments, roadblocks, and challenges along the way to clinic implementation. In the context of noninvasive treating cancer using diet-based and natural biomarkers, we propose a novel machine learning algorithm.

Identifying the probability of genetic mutations in lung cancer using predictive and prognostic biomarkers from histopathological images

“…Ni et al [19] identifies TOP2A, CCNB1, CCNA2, UBE2C, KIF20A, and IL-6 as impending genes associated with the pathogenesis and prognosis of NSCLC. Patil et al [20] uses machine learning methods in cancer prediction and prognosis. To study cellular pH, a variety of methods have been developed, most of which rely on fluorescence indicators and decorated nanoparticles.…”